Pricing Log in Create free account

GSK PLC Sponsored ADR (GSK) vs Nasus Pharma Ltd. (NSRX)

GSK PLC Sponsored ADR and Nasus Pharma Ltd. are both Drug Manufacturers General companies. GSK PLC Sponsored ADR is the larger, with a market value of $101.0B against $34.1M — 2964.8× the size. Across the 9 metrics below, GSK PLC Sponsored ADR leads on 6 and Nasus Pharma Ltd. on 3.

Valuation

Metric GSK NSRX Drug Manufacturers General median
P/E 16.70 — 26.51
P/S 2.24 — 3.49
P/B 4.08 n/m 5.28
Price to free cash flow 11.42 n/m 21.67
EV/EBITDA 10.54 n/m 14.73
EV/Sales 2.86 n/m 4.15
Earnings yield 5.99% — 2.41%
Free cash flow yield 8.76% 0.00% 4.07%

Profitability

Metric GSK NSRX Drug Manufacturers General median
Gross margin 72.64% — 73.01%
Operating margin 17.95% — 18.34%
Net margin 13.02% — 7.31%
Free cash flow margin 19.65% 0.00% 18.56%
Return on equity 25.48% 0.00% 5.80%
Return on assets 6.53% 0.00% 2.28%
Return on invested capital 9.61% 0.00% 6.26%

Growth

Metric GSK NSRX Drug Manufacturers General median
Revenue growth (TTM) 6.90% — 6.72%
EPS growth (last fiscal year) 133.96% (231.82%) 21.81%
Revenue growth, 5-year CAGR (0.32%) — 4.75%
Net income growth, 5-year CAGR 0.42% — 0.00%

Health

Metric GSK NSRX Drug Manufacturers General median
Debt to equity 1.29 0.00 0.62
Current ratio 0.86 8.77 1.39
Net debt to EBITDA 1.39 0.26 1.15

Dividend

Metric GSK NSRX Drug Manufacturers General median
Dividend yield 3.61% — 2.32%
Payout ratio 0.61 — 0.59

Size

Metric GSK NSRX Drug Manufacturers General median
Market cap 101.04b 34.08m 129.04b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack